Revathi Advaithi, CEO of Flex, the $26 billion manufacturer, talks about her strategies to help women excel in business.
Revathi Advaithi deftly commands Flex, a $26 billion manufacturer, because she learned to step outside her comfort zone years ago.
Every year since Advaithi took Flex’s highest spot in 2019, “there has been something pretty significant for me to navigate through,’’ the 55-year-old executive says. During the pandemic, Flex made ventilators for the first time and became one of the biggest makers of lifesaving equipment within nine months. “I now operate well outside my comfort zone because I’ve learned to put my people first in every crisis situation,” she says.
We want every customer to be thinking about how they can better enable a circular economy by repairing, refurbishing, and reusing products and materials where possible. If I make something that stops functioning, I take it back and remake it into something else. And you manage the waste at the time it stops having a useful life. Having that end-to-end view on every product made in this world is the most important [environmental] strategy that our customers can have.
Flex is in the middle of everything that involves rebalancing of supply chains. It is about driving a sustainability improvement [and] most importantly, reducing risks associated with the complex supply chain [such as] manufacturing where you have less control of the geopolitical environment. Shipping things back and forth around the world doesn’t make sense today. But changing that is not simple. We get rewarded to help our customers do complex things.
You recently began holding your managers accountable for hiring, sponsoring, and promoting more female staffers. Describe other ways that you’re trying to improve the status of women within Flex.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
500 years in business, Lancs' very own Clarkson's Farm just keeps on goingLancashire has now got its own answer to Clarkson's Farm - a 500-year-old family-run farm in the heart of the Ribble Valley
Read more »
Low serum anti-Müllerian hormone is associated with semen quality in infertile men and not influenced by vitamin D supplementation - BMC MedicineBackground Anti-Müllerian hormone (AMH) is released by testicular Sertoli cells and of great importance during fetal male sexual development, but less is known about the role of circulating AMH during adulthood. In vitro studies have shown that vitamin D may induce AMH transcription, but a controlled trial investigating the possible effect of vitamin D on serum AMH has not been conducted in men. Methods A single-center, double-blinded, randomized placebo-controlled clinical trial (NCT01304927) conducted in Copenhagen, Denmark. A total of 307 infertile men were included and randomly assigned (1:1) to a single dose of 300,000 IU cholecalciferol followed by 1400 IU cholecalciferol + 500 mg of calcium daily (n=151) or placebo (n=156) for 150 days. Difference in serum AMH was a predefined secondary endpoint. Explorative outcomes were associations between serum AMH and gonadal function in infertile men. The primary endpoint was difference in semen quality and has previously been published. Results Infertile men in the lowest AMH tertile had significantly lower sperm concentration (∆T3-1 16 mill/mL (228%); P | 0.001), sperm count (∆T3-1 55 million (262%); P | 0.001), motile sperm count (∆T3-1 28 million (255%); P | 0.001), progressive motile sperm count (∆T3-1 18 million (300%); P | 0.001), testis size (∆T3-1 2.7 mL (16%); P | 0.001), serum inhibin B (∆T3-1 72 pg/mL (59%); P | 0.001), inhibin B/FSH ratio (∆T3-1 48 (145%); P | 0.001), and higher FSH (∆T3-1 2.6 (38%); P | 0.001) than the tertile of infertile men with highest serum AMH. Vitamin D supplementation had no effect on serum AMH compared with placebo treatment. Conclusions In infertile men, low serum AMH is associated with severely impaired gonadal function illustrated by poor semen quality and lower testosterone/LH ratio. Serum AMH in infertile men was not influenced by vitamin D supplementation.
Read more »
UFC 285 live updates: Jon Jones vs. Ciryl Gane, fight card, time, how to watch and predictionsUFC 285 takes place Saturday night at the T-Mobile Arena in Las Vegas featuring a pair of intriguing title fights. In the main event, longtime UFC light heavyweight champion Jon Jones moves up to heavyweight to take on former interim champion Ciryl Gane. Will a belt at another weight class ensure Jones is the greatest fighter in MMA history? In the co-main event, Valentina Shechenko looks to continue her dominance at flyweight with a bout against top contender Alexa Grasso. Looking to bet either matchup? We got you covered. Stay with The Athletic all night for live breakdowns of UFC 285.How to watchDate: March 4Location: T-Mobile Arena in Las VegasStart time: 10 p.m. ET for main card How to watch: ESPN+ PPVFull card with odds via BetMGMJon Jones (-175) vs. Ciryl Gane (+145)Valentina Shevchenko (-750) vs. Alexa Grasso (+500)Geoff Neal (+380) vs. Shavkat Rakhmonov (-550) Mateusz Gamrot (-225) vs. Jalin Turner (+185) Bo Nickal (-2000) vs. Jamie Pickett (+950) Cody Garbrandt (-175) vs. Trevin Jones (+145) Derek Brunson (+200) vs. Dricus du Plessis (-250) Viviane Araújo (+100) vs. Amanda Ribas (-120) Marc-André Barriault defeats Julian Marquez via second-round TKOIan Garry defeats Song Kenan via third-round TKOCameron Saaiman defeats Leomana Martinez via majority decisionTabatha Ricci defeats Jessica Penne via second-round submissionFarid Basharat defeats Da’Mon Blackshear via unanimous decisionLoik Radzhabov defeats Esteban Ribovic via unanimous decision(Photo: Chris Unger/Zuffa LLC via Getty Images)
Read more »